| Target Price | $331.72 |
| Price | $254.44 |
| Potential | 30.37% |
| Number of Estimates | 51 |
| 51 Analysts have issued a price target Salesforce 2026 . The average Salesforce target price is $331.72. This is 30.37% higher than the current stock price. The highest price target is $464.10 82.40% , the lowest is $223.21 12.27% . | |
| A rating was issued by 59 analysts: 45 Analysts recommend Salesforce to buy, 13 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Salesforce stock has an average upside potential 2026 of 30.37% . Most analysts recommend the Salesforce stock at Purchase. |
56 Analysts have issued a sales forecast Salesforce 2026 . The average Salesforce sales estimate is $41.7b . This is 5.46% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $43.6b 10.43% , the lowest is $40.3b 2.05% .
This results in the following potential growth metrics:
| 2025 | $37.9b | 8.72% |
|---|---|---|
| 2026 | $41.7b | 9.94% |
| 2027 | $45.4b | 9.02% |
| 2028 | $49.8b | 9.73% |
| 2029 | $54.5b | 9.27% |
| 2030 | $59.7b | 9.57% |
| 2031 | $64.2b | 7.66% |
| 2032 | $70.5b | 9.67% |
| 2033 | $77.4b | 9.90% |
26 Analysts have issued an Salesforce EBITDA forecast 2026. The average Salesforce EBITDA estimate is $17.4b . This is 87.46% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $18.6b 99.56% , the lowest is $15.7b 68.74% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $8.6b | 24.34% |
|---|---|---|
| 2026 | $17.4b | 103.48% |
| 2027 | $18.7b | 7.42% |
| 2028 | $19.7b | 5.34% |
| 2029 | $22.2b | 12.67% |
| 2030 | $24.8b | 11.43% |
| 2031 | $17.8b | 28.04% |
| 2032 | $19.7b | 10.49% |
| 2033 | $21.7b | 10.29% |
| 2025 | 22.61% | 14.37% |
|---|---|---|
| 2026 | 41.84% | 85.07% |
| 2027 | 41.23% | 1.46% |
| 2028 | 39.58% | 4.00% |
| 2029 | 40.81% | 3.11% |
| 2030 | 41.50% | 1.69% |
57 Salesforce Analysts have issued a net profit forecast 2026. The average Salesforce net profit estimate is $11.0b . This is 64.66% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.7b 75.48% , the lowest is $10.5b 56.90% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $6.2b | 49.83% |
|---|---|---|
| 2026 | $11.0b | 77.05% |
| 2027 | $12.3b | 11.87% |
| 2028 | $13.9b | 13.57% |
| 2029 | $15.6b | 12.07% |
| 2030 | $17.3b | 10.71% |
| 2031 | $17.8b | 2.79% |
| 2032 | $18.9b | 6.40% |
| 2033 | $20.4b | 8.01% |
| 2025 | 16.35% | 37.82% |
|---|---|---|
| 2026 | 26.34% | 61.07% |
| 2027 | 27.02% | 2.58% |
| 2028 | 27.97% | 3.52% |
| 2029 | 28.68% | 2.54% |
| 2030 | 28.98% | 1.05% |
| 2031 | 27.67% | 4.52% |
| 2032 | 26.85% | 2.96% |
| 2033 | 26.38% | 1.75% |
57 Analysts have issued a Salesforce forecast for earnings per share. The average Salesforce EPS is $11.49 . This is 66.04% higher than earnings per share in the financial year 2025. The highest EPS forecast is $12.24 76.88% , the lowest is $10.95 58.24% .
This results in the following potential growth metrics and future valuations:
| 2025 | $6.36 | 51.43% |
|---|---|---|
| 2026 | $11.49 | 80.66% |
| 2027 | $12.85 | 11.84% |
| 2028 | $14.60 | 13.62% |
| 2029 | $16.36 | 12.05% |
| 2030 | $18.11 | 10.70% |
| 2031 | $18.61 | 2.76% |
| 2032 | $19.81 | 6.45% |
| 2033 | $21.39 | 7.98% |
| Current | 36.77 | 23.27% |
|---|---|---|
| 2026 | 22.15 | 39.76% |
| 2027 | 19.80 | 10.61% |
| 2028 | 17.43 | 11.97% |
| 2029 | 15.56 | 10.73% |
| 2030 | 14.05 | 9.70% |
| 2031 | 13.67 | 2.70% |
| 2032 | 12.85 | 6.00% |
| 2033 | 11.89 | 7.47% |
Based on analysts' sales estimates for 2026, the Salesforce stock is valued at an EV/Sales of 5.65 and an P/S ratio of 5.81 .
This results in the following potential growth metrics and future valuations:
| Current | 5.96 | 20.11% |
|---|---|---|
| 2026 | 5.65 | 5.24% |
| 2027 | 5.18 | 8.27% |
| 2028 | 4.72 | 8.87% |
| 2029 | 4.32 | 8.48% |
| 2030 | 3.94 | 8.74% |
| 2031 | 3.66 | 7.11% |
| 2032 | 3.34 | 8.82% |
| 2033 | 3.04 | 9.01% |
| Current | 6.13 | 19.06% |
|---|---|---|
| 2026 | 5.81 | 5.18% |
| 2027 | 5.33 | 8.27% |
| 2028 | 4.86 | 8.87% |
| 2029 | 4.45 | 8.48% |
| 2030 | 4.06 | 8.74% |
| 2031 | 3.77 | 7.11% |
| 2032 | 3.44 | 8.81% |
| 2033 | 3.13 | 9.01% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JMP Securities |
Market Outperform
➜
Market Outperform
|
Unchanged | Oct 17 2025 |
| Macquarie |
Neutral
➜
Neutral
|
Unchanged | Oct 16 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Oct 16 2025 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Oct 16 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | Oct 16 2025 |
| Wedbush |
Outperform
➜
Outperform
|
Unchanged | Oct 16 2025 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 16 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
JMP Securities:
Market Outperform
➜
Market Outperform
|
Oct 17 2025 |
|
Unchanged
Macquarie:
Neutral
➜
Neutral
|
Oct 16 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Oct 16 2025 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Oct 16 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Oct 16 2025 |
|
Unchanged
Wedbush:
Outperform
➜
Outperform
|
Oct 16 2025 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


